Manufacture; Failure to Supply. (a) Mayne Pharma will manufacture the Product in accordance with all confirmed Orders received from HPPI. (b) In the situation where Mayne Pharma is not able to supply Product, or Mayne Pharma anticipates that it will be unable to supply Product to HPPI in satisfaction of HPPI’s Orders or forecasted Orders, Mayne Pharma shall use reasonable commercial efforts: (i) to inform HPPI in a timely manner about such situation and the details causing such situation; and (ii) to provide HPPI with a reasonable estimate of the length and extent of production interruption or other issue affecting Mayne Pharma’s satisfaction of HPPI’s Product demand.
Appears in 4 contracts
Samples: Supply and License Agreement (HedgePath Pharmaceuticals, Inc.), Supply and License Agreement (HedgePath Pharmaceuticals, Inc.), Supply and License Agreement (HedgePath Pharmaceuticals, Inc.)
